Performance in Initiating and Delivering Clinical Research

Slides:



Advertisements
Similar presentations
NHS R&D Jessica Bisset Acting Research Operations Manager UH Bristol.
Advertisements

AcoRD Implementation Amber O’Malley, CRN Funding and Contracts Manager & AcoRD Business Lead.
UH BRISTOL USING EDGE TO MONITOR OUR KPIs Jess Bisset
Investigator Initiated studies Some data from Benchmarking of Clinical trials in Japan 18 Multi-National and Japanese companies benchmarked their clinical.
Supporting research to make patients, and the NHS, better Update on Clinical Research Network Performance - time for further improvement Dr Jonathan Sheffield.
The Benefits of a Research Active Trust. What is Research? Research is about finding out something new and innovative by combining theory with evidence.
Embedding Research in Practice Judy Lawrence RD PhD
Sub-theme Three The Self-Assessment Process and Embedding QA into the Life of an Institution by Terry Miosi, Ph.D. UAE Qualification Framework Project.
The Role of the Research Office Joint Research & Enterprise Office (JREO) St George’s University of London and St George’s University Hospitals NHS Foundation.
Fellowships Day at Imperial College Sarah Fox 3 rd July 2007.
Access to drugs, Reducing bottlenecks Matt Cooper Business Development & Marketing Director NIHR Clinical Research Network
R&I LEADS - ESSENTIAL DUTIES Attend the Trust R&I Forum. Encourage participation in NIHR Portfolio Research. NEW Work with R&I to ensure the Trust meets.
Delivering clinical research to make patients, and the NHS, better Lymphs & Haems Cancer Research Report Site Specific Group Meeting Wednesday 16 th March.
Performance in Initiating and Delivering Clinical Research Why are we doing this? Through the NIHR (National Institute for Health Research) the Government.
Research and Development Dr Julie Hankin Medical Director.
Systematic QIPP Development Adoption of NHS Right Care
Performance in Initiating and Delivering Clinical Research
London (South) Comprehensive Local Research Network
Performance in Initiating and Delivering Clinical Research
SWAG SSG Sarcoma Meeting
SWAG SSG Skin Cancer Meeting
SWAG SSG Colorectal Cancer Meeting
Maternity and Neonatal, Skin, Vision and Hearing Deep Dive Workshop Understanding “what to change” using the NHS Right Care methodology Part of the NEW.
Training package is appropriate
Measuring CRN HLO 4 for 14/15 Delivering clinical research to
SWAG SSG Upper GI Cancer Meeting
SWAG SSG Upper GI Cancer Meeting
CCBT TEC.
Amanda Lilley-Kelly Senior Trial Co-ordinator
Clinical research in Southampton is a partnership between University Hospital Southampton (UHS) NHS Foundation Trust and the University of Southampton.
The NIHR Southampton Clinical Research Facility was established by the Wellcome Trust and the Department of Health in The NIHR Southampton Clinical.
The Role of the Oral Dental Specialty Group
SWAG SSG Gynaecology Cancer Meeting
SWAG SSG Brain and CNS Cancer Meeting
John Adler Chief Executive, Leicester’s Hospitals
Title The NIHR Southampton Clinical Research Facility was established by the Wellcome Trust and the Department of Health in The NIHR Southampton.
Title Clinical research in Southampton is a partnership between University Hospital Southampton (UHS) NHS Foundation Trust and the University of Southampton.
Performance in Initiating and Delivering Clinical Research
Neurological Services Deep Dive Workshop Understanding “what to change” using the NHS Right Care methodology Part of the NEW Devon Way.
Alexander Harrison MSc
Safe Staffing Reports / NQB
Providing Hope and Opportunity
SWAG SSG Breast Cancer Meeting
SWAG SSG Sarcoma Meeting
Training pack for practices Introduction to dental contract reform
Challenges of Recruitment in Haematology Trials
Cindy Murray NP Princess Margaret Cancer Centre
Title Clinical research in Southampton is a partnership between University Hospital Southampton (UHS) NHS Foundation Trust and the University of Southampton.
SWAG SSG Head and neck Cancer Meeting
Network support for researchers Jonathan Sheffield, Chief Executive
SWAG SSG Sarcoma Cancer Meeting
Clinical research in Southampton is a partnership between University Hospital Southampton (UHS) NHS Foundation Trust and the University of Southampton.
SWAG SSG Lung Cancer Meeting
Safe Staffing (NQB) Report for April 2018
SWAG SSG Skin Cancer Meeting Wednesday 23rd May Research Report
SWAG SSG Haematology and Lymphoma Cancer Meeting
SWAG SSG Lung Cancer Meeting
SWAG SSG Skin Cancer Meeting
ACCORD Update Event Fiona McArdle Deputy R&D Director Wellcome Auditorium Queen’s Medical Research Institute 26th February 2019.
Safe Staffing Reports / NQB
Clinical research in Southampton is a partnership between University Hospital Southampton (UHS) NHS Foundation Trust and the University of Southampton.
How to get support with clinical research studies
[Group Name].
SWAG SSG Breast Cancer Meeting
Title Southampton Clinical Research Facility Southampton Biomedical Research Centre Clinical research in Southampton is a partnership between University.
Clinical research in Southampton is a partnership between University Hospital Southampton NHS Foundation Trust and the University of Southampton, combining.
Lung Cancer Clinical Advisory Group
The NIHR Southampton Clinical Research Facility was established by the Wellcome Trust and the Department of Health in The NIHR Southampton Clinical.
Progress on select dashboard measures as of December 31, 2017.
Progress on select dashboard measures as of December 31, 2017.
Presentation transcript:

Performance in Initiating and Delivering Clinical Research Reporting Period Q1 17/18 - 1/7/2016 to 30/6/2017 Performance in Initiating and Delivering Clinical Research Why are we doing this? Through the NIHR (National Institute for Health Research) the Government wishes to see a dramatic and sustained improvement in the performance of providers of NHS services in initiating and delivering clinical research. The aim is to increase the number of patients who have the opportunity to participate in research and to enhance the nation’s attractiveness as a host for research. From 2013 for clinical trials, the NIHR will publish outcomes against contract NIHR benchmarks. Alder Hey holds one of these contracts. These outcomes include an initial benchmark of 70 days or less from the time a provider of NHS services receives site selection (for HRA approval) to the time when that provider recruits the first patient for that study (Performance in Initiating Clinical Research). It also includes the NHS providers performance in recruiting to time and target for commercial contract clinical trials (Performance in Delivery of Clinical Research).

Performance in Initiating and Delivering Clinical Research Reporting Period Q1 17/18 - 1/7/2016 to 30/6/2017 Performance in Initiating and Delivering Clinical Research Review of Previous Quarter Data (Q4 01/4/2016 to 31/3/2017) Adjusted Report for PI Comparison of Alder Hey Children’s NHS FT against national average Performance in Initiating Mean number of days between receipt of Date Site Selected and date of First Patient Recruited All Providers = 75.7 [SD 57.4]. Alder Hey Children's NHS Foundation Trust = 78.8 days Alder Hey was ranked 80th of 187 Providers. Percentage total trials meeting the 70 day benchmark All Providers = [46% of adjusted trials 29.1% of absolute trials] Alder Hey Children's NHS Foundation Trust = 33.3%. Alder Hey was ranked 83rd of 187 Providers. Performance in Delivery Total closed trials meeting time and target (All Providers) = 55.4% Alder Hey Children's NHS Foundation Trust = 55.6% (of closed trials =9).

NIHR Central Commissioning Facility Reporting Period Q1 17/18 - 1/7/2016 to 30/6/2017 NIHR Central Commissioning Facility 70 day benchmark – Time to first patient recruitment Analysis of Performance in Initiating Clinical Research (70 day benchmark – Time to first patient recruitment) Total Trials Reported – 15 (Every clinical trial opened with HRA approval at Alder Hey within the previous 12 months (01/7/2016 to 30/6/2017) Total trials meeting the 70 day benchmark – 6 (40% of reported trials) Clinical trials that have recruited the first participant within 70 days of a Valid Research Application Total trials still eligible to comply with 70 day benchmark – 0 (0% of reported trials) Clinical trials where 70 day benchmark could still be met at end of reporting quarter Total trials NOT meeting the 70 day benchmark – 9 (60% of reported trials) Clinical trials that either recruited the first patient after the 70 day target elapsed or have not yet recruited and 70 days have already elapsed Of trials not meeting 70 day benchmark (9), total trials where fault lies with NHS provider – 4 (26.6% of reported trials) Clinical trials where reason for failure lies with NHS provider Mean number of Days between Site Selected and First Patient Recruited (# trials recruited to = 15) –63.7 days Median number of Days between Site Selected and First Patient Recruited (# trials recruited to = 15) –55 days

NIHR Central Commissioning Facility Reporting Period Q1 17/18 - 1/7/2016 to 30/6/2017 NIHR Central Commissioning Facility 70 day benchmark – Time to first patient recruitment Performance in Initiating Clinical Research Q1 Table 1 of 3

NIHR Central Commissioning Facility Reporting Period Q1 17/18 - 1/7/2016 to 30/6/2017 NIHR Central Commissioning Facility 70 day benchmark – Time to first patient recruitment Performance in Initiating Clinical Research Table 2 of 3

NIHR Central Commissioning Facility Reporting Period Q1 17/18 - 1/7/2016 to 30/6/2017 NIHR Central Commissioning Facility 70 day benchmark – Time to first patient recruitment Performance in Initiating Clinical Research Table 3 of 3

NIHR Central Commissioning Facility Reporting Period Q1 17/18 - 1/7/2016 to 30/6/2017 NIHR Central Commissioning Facility Recruitment to time and target for commercial contract clinical trials Analysis of Performance in Delivery of Clinical Research (Recruitment to Time and Target) Total Trials Reported – 7 (Clinical trials hosted by Alder Hey Children’s NHS FT and closed within a 12 month period (01/7/2016 to 30/06/2017). Total Trials Closed NOT Meeting Time and Target – 3 Reasons: Studies have rare condition /no patients seen. /Sponsor closed early. Total Trials Closed Meeting Time and Target – 4 (57.1%)

NIHR Central Commissioning Facility Reporting Period Q1 17/18 - 1/7/2016 to 30/6/2017 NIHR Central Commissioning Facility Recruitment to time and target for commercial contract clinical trials Performance in Delivery of Clinical Research Table 1 of 1